02 education & research

2016-2021

UNIVERSITY OF LUCERNE

PhD in Health Economics & Health Policy

Effectiveness of pricing policies for new, innovative health technologies in OECD countries. > publications

2017-2019

SWISS SCHOOL OF PUBLIC HEALTH

PhD Program: International Doctoral Courses in Health Economics & Policy

2005 -2007

UNIVERSITY OF  ST. GALLEN

Master in International Affairs & Governance
Economics, Political Sciences and Law.

2001-2005

UNIVERSITY OF  ST. GALLEN

Bachelor in Business Administration
Additional courses of Bachelor in International Affairs for change of Major on Master level. 

01 Experience

2019-

HSK

Head Analytics & Special Contracts
The HSK Purchasing Cooperative negotiates service contracts (tariffs) with Swiss health care providers on behalf of the three health insurance companies Helsana, Sanitas and KPT, representing approximately 25% of the Swiss mandatory health insurance market.

2016-2018

TAKEDA

Head Market Access & Government Affairs

Member of Swiss Executive Committee,

team head (5 FTE). Responsible for patient access, evidence generation and public affairs activities. Relations with health authorities, trade associations, health insurances, university hospitals. Therapeutic areas: Oncology, Gastroenterology and Primary Care.

2014-2016

ABBVIE

Market Access Manager
Preparation, submission and negotiation of reimbursement & pricing dossiers to / with the national health authority (BAG). Negotiation of individual patient cases with health insurances. Therapeutic areas: Immunology, Neurology, Virology, Oncology and Nephrology.

2012-2014

SWISS RE (SWISS REINSURANCE COMPANY)

Economic Reporting Analyst
Group Planning & Analysis. Analysis and valuation of assets and liabilities based on best estimates of underlying cash flows. Preparation of Swiss Re's EVM disclosure which is basis for regulatory reporting in Switzerland (FINMA) and the rest of the world. 

2009-2011

HIRSLANDEN PRIVATE HOSPITAL GROUP

Executive Assistant, CEO team

Reporting for Board of Directors, Executive Committee and Clinic Directors. Presentations and briefings for CEO, General Secretary,  Head Public Affairs. Support in strategy, corporate / business development, acquisitions, public policy, etc. 

2008

KANTONSSCHULE TROGEN

Teacher (part-time)

Subjects: Business Administration, Economics & Law

2007-2009

DEPARTMENT OF JUSTICE & HOME AFFAIRS, CANTON ZH

Research Assistant to Chief of Office

Legislative project to reform the Cantonal Act on Fiscal Compensation. Economic modelling for the new regulation, preparation of governmental communiques / decrees, responses to formal requests from the Cantonal parliament. 

 
 
 
CONTACT

Please feel free to drop me a line ___

  • White LinkedIn Icon
  • Withe xing icon
  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon

dominik wettstein.

HEALTH ECONOMIST

DW

A future-proof Swiss healthcare system needs more evidence and transparency on outcomes and costs, more cross-sectoral, cross-regional collaboration across the entire treatment cycle, as well as “learning reimbursement systems”.

A future-proof Swiss healthcare system needs more data, evidence and transparency regarding medical outcomes and the associated costs. Only by establishing an informed discussion on added value (ratio of additional patient outcome to additional costs) and corresponding reimbursement systems will we promote the “right innovations” which we can also afford in the long term. For the benefit of patients and society.

All partners in the health care system (manufacturers, service providers, insurers and authorities) must commit to the improved availability of data, evidence and transparency. However, not only evidence and transparency are needed, but also consequence: therapy offers must be committed to their added value (“value-based pricing”). Evidence-based minimum case numbers per therapy area must be defined and enforced for service providers. New therapies must be regularly reviewed for their effectiveness and cost-effectiveness.

There is also a need for improved cooperation between all actors in all areas of care planning and service provision. For Switzerland, this requires in particular supra-regional care planning: our fragmented hospital landscape urgently needs more consolidation.

Above all, however, a sustainably financeable Swiss health system can only be guaranteed if we establish “learning reimbursement systems” in all service and tariff areas that are able to reflect progress in medicine, technology and the organisation of service provision.

  • White LinkedIn Icon
  • Withe xing icon
  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon

Zürich, Switzerland